Skip to main content
Fig. 2 | Pediatric Rheumatology

Fig. 2

From: Colchicine – an effective treatment for children with a clinical diagnosis of autoinflammatory diseases without pathogenic gene variants

Fig. 2

Colchicine response in children with a clinical AID diagnosis without pathogenic gene variants. Legend: Percentages of children with a clinical AID diagnosis without pathogenic gene variants with complete (PGA ≤2 cm plus CRP ≤0.5 mg/dL and/or SAA ≤10 mg/L), partial (PGA > 2 ≤ 5 cm plus CRP > 0.5 mg/dL ≤5 mg/dL and/or SAA > 10 mg/L ≤ 50 mg/L) and no (PGA > 5 and/or CRP > 5 mg/dL and/or SAA > 50 mg/L) colchicine response. Complete response was achieved in > 50% of patients, a third had a partial response and no response was achieved in ≤10%. Abbreviations: N patients number, SAA serum amyloid A, CRP C-reactive protein, PGA physician global assessment, mg milligram; dL decilitre; L litre

Back to article page